[ORGANIZATION]
Vontobel
Featured in 4 tracked stories · first seen
Situations
Novartis CAR T cell therapy trial suspensions
2 clusters · 34 sources · last updated
Latest: Novartis shares plunge following dual clinical trial failures
Novartis has halted eight clinical trials involving an experimental CAR T cell therapy following three deaths. The fatalities were linked to immune effector cell-associated hemophagocytic syndrome (IEC-HS), a condition w
Munich Re financial performance and stock trend
4 clusters · 12 sources · last updated
Latest: EvoNext Holdings confirms advanced merger talks with Ascend Sport Technology
In mid‑July 2026 Munich Re’s shares regained momentum, breaking above the 100‑day moving average and retaking the €507.20 support level, with the next hurdle near the 200‑day average at €524.16. The insurer’s 2024 result
Also covered in
-
Vontobel relocation to Zug downplayed by Zurich finance chief
[BUSINESS] · 2 sources ·